Stockscreener 앱 받기
3.20
0.62%
-0.02
전일 마감가:
$3.22
열려 있는:
$3.25
하루 거래량:
27,971
Relative Volume:
0.18
시가총액:
$4.01M
수익:
$72,100
순이익/손실:
$-4.84M
주가수익비율:
-0.4292
EPS:
-7.4566
순현금흐름:
$-3.84M
1주 성능:
-14.32%
1개월 성능:
-37.62%
6개월 성능:
-26.69%
1년 성능:
-69.18%
1일 변동 폭
$3.09
$3.34
1주일 범위
$2.75
$3.90
52주 변동 폭
$2.75
$15.15
Silo Pharma Inc Stock (SILO) Company Profile
명칭
Silo Pharma Inc
전화
(718) 400-9031
주소
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc 주식(SILO)의 최신 뉴스
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - quiverquant.com
A nasal PTSD treatment is patented for use before extreme stress - Stock Titan
Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com
QwikAgents' planned AWS platform is expected to improve security and scale - Stock Titan
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
SILO|Silo Pharma Inc|Price:4.210|Chg%:+0.020 - tradingkey.com
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - tradingview.com
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Silo Pharma Inc. Q4 2023 Earnings: Wider-Than-Expected Loss Weighs on SharesFull Year Guidance - dars.gov.et
Silo Pharma Inc (SILO) Income Statement - TradingKey
SILO|Silo Pharma Inc|Price:4.470|Chg%:+0.010 - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Form S-3 Silo Pharma Inc For: 24 July - Investing.com India
Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com South Africa
Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView
Silo Pharma Advances AI Agent Platform Toward Commercial Launch And Progresses Lead PTSD Drug Program SPC-15 - marketscreener.com
Silo Pharma plans AI platform launch, advances PTSD drug program By Investing.com - Investing.com Canada
Silo Pharma Advances QwikAgents Commercial Launch and SPC-15 Development - Quiver Quantitative
Silo Pharma expects its PTSD nasal-spray study to finish in 60 days - Stock Titan
Silo Pharma raises $4 million in private placement By Investing.com - Investing.com Nigeria
Silo Pharma, Inc. (SILO) Stock: Slide 4.92% as QwikAgents Joins AMD AI Developer Program - CoinCentral
Silo Pharma (SILO) Q4 2023 Earnings: EPS Misses by Wide Margin, No Revenue Reported; Stock Gains 1.89%Gross Profit Margin - po-news-eg.net
Silo Pharma unit eyes faster AI agent development through AMD partnership - MSN
Silo Pharma (SILO) completes $4,000,015 private exempt securities sale - Stock Titan
Silo Pharma Advances AI Integration and PTSD Treatment Development - sekbernews.id
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? - Yahoo Finance
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program to Accelerate AI Agent Platform - citybuzz -
Silo Pharma (SILO) Shares Drop 4.92% Following QwikAgents' Entry into AMD AI Developer Program - Blockonomi
Why Is Silo Pharma Stock Volatile Today?SILO Pharma (NASDAQ:SILO) - Benzinga
Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform - Yahoo Finance
Silo Pharma subsidiary joins AMD AI developer program By Investing.com - Investing.com Canada
Silo Pharma’s QwikAgents Accepted Into AMD AI Developer Program - Quiver Quantitative
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - 富途牛牛
Silo Pharma Raises Approximately $3.5 Million Net in Private Placement; Grants Resale Rights - TradingView
SILO Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces HeadwindsEBITDA Analysis - DonanımHaber
Number of shareholders of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to earnings forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to sales forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Enterprise value to EBIT forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall - Investing.com Canada
SILO: H.C. Wainwright & Co. Leads Exclusive Offering - GuruFocus
Silo Pharma (SILO) Stock Tumbles 28% Following $4M Financing Announcement - Blockonomi
Silo Pharma (SILO) Stock: Shares Plunge 28% After $4 Million Private Placement - CoinCentral
Silo Pharma Inc (SILO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):